Notably HPV-positive (and p16-positive) patients were reported to be less likely to have recurrence and there were no vulvar cancer related deaths, whereas p53-mutant positive patients had a greater probability of recurrence and were significantly more likely to die from vulvar cancer [53]. The gene discussed is TP53; the disease is vulva cancer.